文献速递外周动脉疾病

退伍军人下肢外周动脉疾病的流行病学研究

Epidemiology of lower extremity peripheral artery disease in veterans.
PubMed 文献 · J Vasc Surg · 2018-03-24

该研究利用美国退伍军人健康管理局2009至2011财年全国数据,识别新诊断外周动脉疾病(PAD)的退伍军人175,865例,描述其临床特征、推荐药物使用及3年随访结局。结果显示合并症负担重、他汀处方不足,随访期间死亡和肢体不良事件风险显著。

要点

  • 新诊断PAD退伍军人175,865例,平均年龄69.9岁,97.8%为男性,67.7%为白人。
  • 77%合并高血压,46.5%合并糖尿病,12.9%合并肾衰竭;60.8%在诊断后90天内配取他汀,34.9%接受高强度他汀。
  • 中位随访3.8年期间28.6%死亡(1年时6.7%),3.7%发生肢体不良结局(1年时2.0%)。

核心结论

  • 退伍军人PAD患者合并症患病率高,死亡和肢体丧失风险显著。
  • 相当比例退伍军人PAD患者未接受推荐药物治疗,尤其是他汀治疗。
  • 数据凸显改善退伍军人PAD患者照护的重要机会。

研究设计与样本

  • 利用美国退伍军人健康管理局2009至2011财年全国数据识别新诊断PAD患者。
  • 共纳入175,865例新诊断PAD患者。
  • 随访3年(2014财年),采用Cox比例风险回归分析死亡和肢体不良结局的预测因素。

主要发现

  • 平均年龄69.9岁;97.8%为男性,67.7%为白人。
  • 77%合并高血压,46.5%合并糖尿病,23%合并慢性阻塞性肺疾病,12.9%合并肾衰竭。
  • 60.8%在PAD诊断后90天内配取他汀,34.9%接受高强度他汀。
  • 1年时2.6%接受血运重建,1.3%发生CLI,1.1%接受截肢。
  • 中位随访3.8年期间28.6%死亡(1年时6.7%),3.7%发生肢体不良结局(1年时2.0%)。

关键数值与推荐

  • 死亡预测因素包括高龄、合并症以及就诊时存在CLI或截肢。
  • 他汀处方与较低死亡风险相关。
  • 肢体不良结局预测因素类似,但高龄与较低的截肢或CLI风险相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to describe the epidemiology, clinical features, outcomes, and predictors of mortality in veterans with peripheral artery disease (PAD). METHODS: We used national data from the Veterans Health Administration from fiscal years 2009 to 2011 to identify patients with a new diagnosis of PAD. Within this cohort, we describe characteristics of the patients, use of recommended medications, and clinical outcomes during a 3-year follow-up (fiscal year 2014). We used Cox proportional hazards regression to examine predictors of mortality and adverse limb outcomes (amputation and hospitalization for critical limb ischemia [CLI]) during follow-up. RESULTS: A total of 175,865 patients with a new diagnosis of PAD were included. The mean age was 69.9 years; 97.8% were male, and 67.7% were white. Nearly 77% of patients had hypertension, 46.5% had diabetes, 23% had chronic obstructive pulmonary disease, and 12.9% had renal failure. A prescription for statins was filled by 60.8%, and 34.9% received high-intensity statins within 90 days of PAD diagnosis. At 1 year, 2.6% underwent revascularization, 1.3% developed CLI, and 1.1% underwent amputation. During a median follow-up of 3.8 years, a total of 28.6% patients died (6.7% at 1 year), and 3.7% developed a limb outcome (2.0% at 1 year). Predictors of mortality included advanced age, comorbidities, and CLI or amputation at presentation. In contrast, prescription with statins was associated with lower mortality. Similar findings were present with regard to predictors of adverse limb outcomes, except that older age was associated with a lower risk of amputation or CLI. CONCLUSIONS: We found that veterans with PAD have a high prevalence of comorbid conditions and have a significant risk of mortality and limb loss. A substantial proportion of veterans with PAD are not prescribed recommended medications, especially statin therapy. Our data highlight important opportunities for improving care of veterans with PAD.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Willey J, Mentias A, Vaughan-Sarrazin M, et al. Epidemiology of lower extremity peripheral artery disease in veterans. J Vasc Surg. 2018. PMID: 29588132. doi:10.1016/j.jvs.2017.11.083

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。